India’s first case of deadly Mpox variant Clade 1b, WHO declares it dangerous

WhatsApp Group Join Now
Telegram Group Join Now

A patient with the lethal clade 1b variant of Mpox has been confirmed in India. The case came to light in the Malappuram district of Kerala, where the deadly mutation was found in a 38-year-old man. He recently returned from the United Arab Emirates.

Government sources said, “This is the first case of Mpox clade 1b in the country. The man developed fever and a chickenpox-like rash, after which doctors became suspicious and sent his sample for testing.” This is the second case of Mpox in India. cases. The first case was reported in Delhi, but the case was classified as Clade-2, which is separate from the WHO public health emergency. Recent cases are linked to this warning from the World Health Organization.

Also read: Mpox patient admitted to LNJP Hospital, admitted since September 8, has been discharged.

Mpox clade 1b spread rapidly

Mpox clade 1b spreads rapidly. According to the World Health Organization, the virus, which is spread mainly through sexual networks, has become a major crisis in neighboring countries of the Democratic Republic of Congo (DRC). Mpox was formerly known as monkeypox, but the World Health Organization changed its name. The virus has long been a major health concern in African countries.

223 people worldwide died from MPOX

According to the World Health Organization, Mpox cases have been reported in 121 member countries since January 1, 2022. This information has been given in the World Health Organization’s report, which states that 102,997 cases have been confirmed worldwide. Apart from this, 223 deaths were also recorded. This year, there were 1,425 cases and six deaths in July alone.

Also Read: Suspected Mpox case in Malappuram, Kerala, person returned from Dubai.

African countries have the highest number of cases

55% of MPOX cases occur in African countries. In addition, 24% of cases were found in the Americas and 11% in Europe. The Southeast Asia Region (SEAR) accounts for 1% of total cases. India has set up hospitals and laboratories to address the problem.

WhatsApp Group Join Now
Telegram Group Join Now